埃尔特罗姆博帕格
医学
再生障碍性贫血
挽救疗法
肿瘤科
内科学
化疗
血小板
骨髓
免疫性血小板减少症
标识
DOI:10.1016/s2352-3026(24)00003-6
摘要
In The Lancet Haematology, Phillip Scheinberg and colleagues1 report the results of the SOAR trial, a multicentre, phase 2 trial investigating cyclosporine and eltrombopag combination therapy for patients with treatment-naive severe aplastic anaemia.
科研通智能强力驱动
Strongly Powered by AbleSci AI